Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:advocatesFor |
drug safety reforms
|
| gptkbp:birthYear |
1949
|
| gptkbp:criticizedFor |
gptkb:Vioxx
rosiglitazone (Avandia) |
| gptkbp:education |
gptkb:University_of_Michigan
gptkb:University_of_Michigan_Medical_School |
| gptkbp:employer |
gptkb:Cleveland_Clinic
|
| gptkbp:field |
cardiology
|
| https://www.w3.org/2000/01/rdf-schema#label |
Steven Nissen
|
| gptkbp:knownFor |
clinical trials
drug safety advocacy research on cardiovascular drugs |
| gptkbp:memberOf |
gptkb:American_College_of_Cardiology
gptkb:National_Academy_of_Medicine |
| gptkbp:nationality |
gptkb:American
|
| gptkbp:occupation |
gptkb:physician
cardiologist |
| gptkbp:position |
Chief Academic Officer
Chairman of Cardiovascular Medicine |
| gptkbp:publishedIn |
numerous scientific articles
|
| gptkbp:spouse |
Dr. Marcella A. Nissen
|
| gptkbp:bfsParent |
gptkb:The_Cleveland_Clinic
|
| gptkbp:bfsLayer |
7
|